e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Noninvasive evaluation of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Breath glucose measurements in asthma and alveolitis patients during exacerbation and after steroids
S. Akunuri, C. Wells, D. Fisher, N. Clark, E. Baker (London, United Kingdom)
Source:
Annual Congress 2007 - Noninvasive evaluation of airway diseases
Session:
Noninvasive evaluation of airway diseases
Session type:
Electronic Poster Discussion
Number:
520
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Akunuri, C. Wells, D. Fisher, N. Clark, E. Baker (London, United Kingdom). Breath glucose measurements in asthma and alveolitis patients during exacerbation and after steroids. Eur Respir J 2007; 30: Suppl. 51, 520
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Endothelin -1 in exhaled breath condensate during omalizumab therapy in patients with severe persistent allergic asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005
Effects of inhaled corticosteroids on breath condensate inflammatory markers in childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 41s
Year: 2005
Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Induced sputum concentrations of mucin in patients with asthma and chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 61s
Year: 2007
8-isoprostane in breath condensate in patients with exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline
Source: Annual Congress 2005 - Therapeutic options for COPD: present and future
Year: 2005
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept